1576 - 1600 of 6509 Results
Title
Year
-
OPENTitle: Genetic variability in the regulation of gene expression in ten regions of the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page: 1418End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3801Best OA location URL: http://doi.org/10.1038/nn.3801Citation Count: 656
-
OPENTitle: Quantitative EEG as a predictive biomarker for Parkinson disease dementiaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 2Start Page: 118End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318224af8dBest OA location URL: https://n.neurology.org/content/neurology/77/2/118.full.pdfCitation Count: 201
-
OPENTitle: Evidence-based guideline update: Treatment of essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 19Start Page: 1752End Page: 1755Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318236f0fdBest OA location URL: https://n.neurology.org/content/neurology/77/19/1752.full.pdfCitation Count: 327
-
OPENTitle: Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 133Issue #: 5Start Page: 839End Page: 856Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-017-1685-yBest OA location URL: http://doi.org/10.1007/s00401-017-1685-yCitation Count: 237
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes2014OPENTitle: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 752End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4082726Citation Count: 198
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects2014OPENTitle: Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction EffectsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 2Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2757Citation Count: 151
-
OPENTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 487
-
OPENTitle: Age-related changes in glutathione and glutathione-related enzymes in rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1090Issue #: 1Start Page: 35End Page: 44Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2006.03.063Best OA location URL: http://doi.org/10.1016/j.brainres.2006.03.063Citation Count: 271
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial2017OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Citation Count: 731
-
OPENTitle: Disease duration and the integrity of the nigrostriatal system in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 8Start Page: 2419End Page: 2431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt192Best OA location URL: https://academic.oup.com/brain/article-pdf/136/8/2419/11140480/awt192.pdfCitation Count: 1270
-
OPENTitle: (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylationJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 1114End Page: 1130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201540514Best OA location URL: http://doi.org/10.15252/embr.201540514Citation Count: 165
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011OPENTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Citation Count: 84
-
OPENTitle: CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohortsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 11Start Page: 1470End Page: 1481Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2018.01.010Best OA location URL: https://doi.org/10.1016/j.jalz.2018.01.010Citation Count: 664
-
OPENTitle: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 117Issue #: 6Start Page: 613End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-009-0538-8Best OA location URL: http://doi.org/10.1007/s00401-009-0538-8Citation Count: 639
-
OPENTitle: Central nervous system uptake of intranasal glutathione in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2016.2Best OA location URL: https://www.nature.com/articles/npjparkd20162.pdfCitation Count: 53
-
OPENTitle: Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression AnalysisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2016.00046Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2016.00046/pdfCitation Count: 35
- Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease2016OPENTitle: Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1012End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26621Best OA location URL: http://doi.org/10.1002/mds.26621Citation Count: 35
-
OPENTitle: Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 64Issue #: 3Start Page: 995End Page: 1007Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-180088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6082178Citation Count: 20
-
OPENTitle: Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 128Issue #: 2Start Page: 605End Page: 616Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2016.11.jns161162Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/128/2/article-p605.pdfCitation Count: 132
-
OPENTitle: Network correlates of the cognitive response to levodopa in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 858End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c6224Best OA location URL: https://n.neurology.org/content/neurology/77/9/858.full.pdfCitation Count: 64
-
OPENTitle: Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed weldersJournal Name: Occupational and Environmental MedicinePublisher: BMJVol: 69Issue #: 6Start Page: 437End Page: 443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/oemed-2011-100119Best OA location URL: https://oem.bmj.com/content/oemed/69/6/437.full.pdfCitation Count: 108
-
OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 32
-
OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2016.03.002Citation Count: 79
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Citation Count: 26
-
OPENTitle: Glial scars are permeable to the neurotoxic environment of chronic stroke infarctsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 63End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.007Best OA location URL: https://doi.org/10.1016/j.nbd.2018.01.007Citation Count: 113